3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole has been researched along with fluoxetine in 1 studies
Studies (3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole) | Trials (3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole) | Recent Studies (post-2010) (3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole) | Studies (fluoxetine) | Trials (fluoxetine) | Recent Studies (post-2010) (fluoxetine) |
---|---|---|---|---|---|
10 | 3 | 3 | 10,100 | 1,663 | 3,263 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, JD; Shih, JC | 1 |
1 other study(ies) available for 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole and fluoxetine
Article | Year |
---|---|
Evidence for two conformational states of 5-hydroxytryptamine carrier in rat cortical synaptosomes.
Topics: Animals; Azides; Cerebral Cortex; Fluoxetine; In Vitro Techniques; Kinetics; Male; Molecular Conformation; Photolysis; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Sodium; Synaptosomes | 1987 |